Thought Leadership

Risk Minimization with an Integrated Global Network

International relationships are evolving rapidly. In this time of constant change and uncertainty, pharmaceutical outsourcing, while still offering many benefits, may also carry added risk — unless the outsourcing partner operates a highly integrated global network, has manufacturing locations in key growth markets and brings decades of experience to the table.

Thought Leadership

Accelerating Time to Market with Integrated Preparative Chromatography Support

With reduced purification times, higher target molecule purities and the ability to quickly separate and identify impurities, preparative chromatography can provide a greater understanding of products and processes while reducing time to the clinic and the market.

 

Press Release

Servier Launches InnoPreP™, Its new Preparative Chromatography Offer Under Its Contract Development & Manufacturing Activity

Paris, France, October 1, 2018 – Servier, an independent international pharmaceutical company, today announced the launch of InnoPreP™ – a new preparative chromatography service offered under its contract development and manufacturing business.

Thought Leadership

Reducing Time to Market with Targeted Regulatory Affairs Support

Regulatory affairs activities are essential components of any drug development and commercialization program. CDMOs with extensive experience with product approvals that have regulatory affairs deeply integrated with other operational teams can provide optimized regulatory strategies.

Thought Leadership

Corporate Social Responsibility as a Driver for Improved Sustainability

 The pharmaceutical industry must respond to growing expectations for product safety, the conduct of clinical trials, access to therapeutic care and the environmental impact of medicinal products and manufacturing. Servier Group formalized its Corporate Social Responsibility (CSR) strategy to integrate and communicate the actions it is taking in collaboration with internal and external stakeholders.

Press Release

Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

Servier Group is proud to announce that it will develop its presence in the US market through the oncology therapeutic area. Servier CDMO, in accordance with the group’s strategy, continues to develop its services for High Potent drugs in API and drug product.

News

Welcome to the New Home Page for Servier’s CDMO Business

We are proud to unveil our newly designed home page highlighting Servier’s embedded contract development and manufacturing capabilities. Each month, we will be featuring one of our 16 global manufacturing facilities, as well as a new thought leadership piece on a timely, industry-relevant topic.

Events

Meet us at BIO-Europe Fall 2018

We will be attending BIO-Europe Fall in Copenhagen from 5th–7th November. 

Events

Visit us at CPhI Worldwide

We will be exhibiting at CPhI Worldwide in Madrid from October 9-11.

Events

Visit us at Chem-Outsourcing

We will be exhibiting at Chem-Outsourcing in Long Branch, NJ from September 17-19, booth number 71.

Events

Meet us at Nordic Life Science Days

We will be attending Nordic Life Science days in Stockholm from September 10-12.

Events

Meet us at ChemSpec Europe

We will be attending ChemSpec Europe in Cologne from June 20-21.

Events

Meet us at BIO International

We will be attending BIO International in Boston from June 4-7.

Events

Visit us at CPhI North America

We will be exhibiting at CPhI North America in Philadelphia from April 24-26, booth number 1507.

News

Meet Servier at CPhI North America 2018

Servier will be exhibiting its CDMO capabilities at CPhI North America in Philadelphia, PA from April 24-26, 2018.

Thought Leadership

Transforming a CDMO Using an Operational Excellence Approach

To improve productivity and efficiency, reduce costs and environmental impacts and enhance quality assurance, Servier CDMO is implementing an operational excellence (OPEX) continuous improvement program. Mini-transformations across multiple sites are enabling the company to provide significant added value to its clients and build greater trust with all stakeholders.

 

News

Servier Wins 11 CMO Leadership Awards

Servier is proud to announce we have been recognized across 11 categories in the 2018 CMO Leadership Awards, meeting or exceeding customer expectations in the core categories of Capabilities, Compatibility, Expertise, Quality, Reliability and Service, and receiving individual attribute awards in the areas of On-Time, Reputation, Right First Time, State-of-the-Art and Strength of Science.

Thought Leadership

Why Business Continuity Management is Important for CDMOs

Pharma’s Almanac Q1 2018

Members of the pharmaceutical industry have a responsibility to guarantee both the supply of high-quality medicines and the safety of their personnel. Servier has implemented a global business continuity management strategy to reduce the likelihood of incidents and minimize any consequent impact on its operations.

Events

Meet us at Pharma Synergy

We will be attending Pharma Synergy in Rome from March 22-23.

Events

Meet us at DCAT Week

We will be attending DCAT Week in NYC from March 18-22.

Events

Meet us at BIO-Europe Spring

We will be attending BIO-Europe Spring in Amsterdam from March 12-14.

Events

Meet us at EuroPLX 66

We will be attending EuroPLX N66 in Lisbon from March 5-6.

Thought Leadership

Achieving Efficient Pharmaceutical Synthesis with Process Intensification

Reducing the time, cost and environmental footprint of manufacturing processes continues to be a major driver of technology development. Process intensification for small molecule API production using flow chemistry technologies gives our clients greater opportunities to implement optimum process solutions on the commercial scale.

News

Servier expands Preparative Chromatography platform at Normandy Site to support market need

The benefit is the speeding up of clinical supply and subsequent manufacture of complex molecules for medicines at commercial scale.

Thought Leadership

Russian Pharma Market Offers Great Potential for Local Manufacturers

The Russian market presents new growth opportunities for pharmaceutical companies with manufacturing capabilities within the country. Servier Group is well-positioned to serve the market directly with a wide range of solid oral dose products, while Servier CDMO can support other pharmaceutical companies looking to leverage the growth potential but who lack in-country production facilities.

Thought Leadership

Serialization: The First Steps in Sales Unit Traceability and Data Management

Pharma’s Almanac Q2 2017

Increasing numbers of countries around the world are requiring some level of unit traceability in the pharmaceutical industry. While initially driven by regulations, the impacts of serialization will be far-reaching. Early adopters that implement a strategy that goes beyond compliance to leverage the vast quantities of newly generated data will be well positioned for success in the digital age.

Thought Leadership

Servier Offers Quality Service

Interview originally published on 06/04/2017 at Pharma's Almanac

Thought Leadership

Benefitting from Embedded Quality for End-to-End Success

Interview originally published on 06/04/2017 at Pharma's Almanac

News

Launch of new website

Servier has just launched a new website for our embedded contract development and manufacturing organization (CDMO). You can now find out about our products, services and expertise in the development and manufacture of clinical to commercial drug substance and product. You can also view key information about services and key equipment at each of our manufacturing sites around the world.

Thought Leadership

Enhancing Responsiveness with Embedded Flexibility

Pharma’s Almanac Q1 2017

In today’s pharmaceutical marketplace, speed to market is absolutely crucial. CDMOs with built-in flexibility are ideally situated to help drug companies shorten development and commercialization time lines. Flexibility can take many forms — from rapid tech transfer within an internal network to agile manufacturing configurations and use of automation, to the ability to rapidly respond to changing market and customer needs.

Thought Leadership

Cultivating a Proactive Quality Culture

Preventing patient risk is perhaps the most important goal for any pharmaceutical manufacturer. The quality of a drug substance or product is directly linked to where and how it’s made. As a result of the gravity of production, management must ensure that process variation is eliminated, consistent quality is guaranteed and there are no threats of defects that may potentially harm patients or interrupt supply. To assure quality, Servier takes a holistic approach, bringing people, process and policy together to create an efficient, agile QA/QC culture. 

Thought Leadership

Evolving Strategic Partnership Models

Pharmaceutical development is growing as the industry gains momentum in response to a broad range of market, regulatory and social trends globally. Advancing science, emerging markets and healthcare models are driving recent innovation and therapeutic success in the pharmaceutical sector, which has become increasingly dependent on partnerships across the supply chain. Collaboration is key to successfully responding to market demand – collaboration between both (bio)pharmaceutical companies and their service providers.

Thought Leadership

Leveraging Effective Partnering Models

Manufacturing Chemist – September 2016.

Accelerating successful drug development to meet global demand.

 

Information Download

Tianjin, China

Servier Tianjin Pharmaceutical Co. Ltd was registered in 2000. It is situated in the Tianjin Economic Technological Development Area, (TEDA) which is ranked as one of the top economic development zones in China. The site is located 45km from Tianjin and 120km from Beijing.

Information Download

Jacarepagua, Brazil

Servier Brazil has been established for 40 years. We acquired a new industrial facility in 1995, located in Petropolis, about 75km from Rio de Janeiro. The Petropolis site produced sprays for the local market, repacking local production and QC analysis for imported product.

Information Download

Cairo, Egypt

Servier Egypt has two sites, situated a kilometer apart at Acacias and Palmiers, 50km from Cairo.

The Acacias site is dedicated to manufacturing activities — consisting of a complete granulation suite, four compression units and two coating pans — alongside Quality Control, Quality Assurance and IT. The Acacias site was built in 1994 and fully renovated in 2010.

Information Download

Nouasseur, Morocco

Servier has been present in Morocco since 1970 producing medicines for the Moroccan market initially under license. In 2002, Servier built a pharmaceutical manufacturing site dedicated to dry forms at the Nouasseur science park situated 25km from Casablanca.

Information Download

Toledo, Spain

Toledo, Spain is located 70km from Madrid. Our CDMO facility has 38 years of experience in fine chemistry, specializing in process development, analytical development and manufacturing. Our manufacturing processes us the most up to date production equipment and control techniques.

Information Download

Madrid, Spain

Servier was first established in Madrid, Spain in 1957. In the 1960s the first pharmaceutical manufacturing operations started, dedicated to domestic market. In 1978, the chemical plant of Toledo was built and in 1982, the Madrid functions moved to the new site.

Information Download

Moscow, Russia

Servier Russia is located in Moscow and has been in operation since 2007. The site has one production unit that is dedicated to dry forms manufacturing.

Information Download

Warsaw, Poland

Manufacturing activities were established in Warsaw 20 years ago. In that time, we have focused on providing high quality pharmaceutical products to patients in Poland and beyond.

Information Download

Arklow, Ireland

Servier (Ireland) Industries Ltd. was established in 1989 and is located in South Dublin. It is now the largest production facility outside France for the Servier group, and is the second strategic location in Servier’s worldwide pharmaceuticals operations. 

Information Download

Gidy, France

Gidy is located near Orleans, 100km from Paris. The site was built in 1972 and has 4 production units: two dedicated to dry forms, one dedicated to liquid and spray forms nearby in Fleury-les-Aubrais, and one additional unit that is currently being transformed into a biotechnology unit, launching in 2019.

Information Download

Bolbec, France

Oril Industrie is one of the two full cGMP chemical production sites of Servier’s contract development and manufacturing network, located in Bolbec (Normandy), between Le Havre and Paris. The Bolbec facility specializes in intermediates and APIs development, production and distribution. Industrial R&D and the production units are at the same location, providing flexibility and efficient processes.

Information Download

Supply Chain

Servier CDMO offers a full range of contract development and manufacturing services, from concept and product development to analytical testing, commercial scale and regulatory approval.

Information Download

Packaging

Servier CDMO offers a full range of contract development and manufacturing services, from concept and product development to analytical testing, commercial scale and regulatory approval.

Information Download

Drug Product

Servier CDMO offers a full range of contract development and manufacturing services, from concept and product development to analytical testing, commercial scale and regulatory approval.

Information Download

Drug Substance

Servier CDMO offers a full range of contract development and manufacturing services, from concept and product development to analytical testing, commercial scale and regulatory approval.

Information Download

Clinical Supply

Servier CDMO offers a full range of contract development and manufacturing services, from concept and product development to analytical testing, commercial scale and regulatory approval.